Skip to main content

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) Investor Securities Class Action Lawsuit 08/17/2023

  • If you purchased a significant amount of shares of Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) between January 5, 2022 and July 24, 2023, and / or if you purchased any NASDAQ: INFI shares prior to January 2022 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: October 16, 2023. NASDAQ: INFI investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

August 17, 2023 - An investor in shares of Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Infinity Pharmaceuticals, Inc. in connection with certain allegedly false and misleading statements made between January 5, 2022 and July 24, 2023. Cambridge, MA based...



You must register (for free) or login to view the entire case.